V1rc1 inhibitors constitute a specialized chemical class designed to interact with and inhibit the function of the V1rc1 protein. These inhibitors are characterized by their distinctive chemical structures, which often include a variety of functional groups and molecular motifs tailored to bind specifically to the V1rc1 protein. The core structure of these inhibitors may feature a combination of heterocyclic rings, aromatic systems, and aliphatic chains, each contributing to the overall binding affinity and specificity of the compound. The inhibitors are designed to interact with the protein's active site or an allosteric site, thereby affecting its function.
The design process of V1rc1 inhibitors involves a multi-step synthesis approach where chemists construct complex molecules through various organic reactions. This often includes the incorporation of diverse functional groups to enhance the binding interactions with the target protein. Advanced techniques such as molecular modeling, docking studies, and structural analysis are employed to predict and optimize how these inhibitors bind to V1rc1. This iterative design process ensures that the inhibitors achieve high selectivity and potency by fine-tuning their chemical properties and interactions with the protein. The development of these inhibitors requires a detailed understanding of the V1rc1 protein's structure and function, guiding the creation of molecules that effectively modulate its activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
A cell-permeable calcium chelator that can indirectly affect V1R10 by altering intracellular calcium levels, crucial for signal transduction. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Functions as a tyrosine kinase inhibitor, which could indirectly impact V1R10 signaling by inhibiting downstream signaling pathways. | ||||||
KT 5720 | 108068-98-0 | sc-3538 sc-3538A sc-3538B | 50 µg 100 µg 500 µg | $138.00 $220.00 $972.00 | 47 | |
A PKA inhibitor that could modulate the signaling pathways involved in V1R10 function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, potentially affecting the signaling pathways in which V1R10 participates. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An MEK inhibitor, potentially influencing V1R10 activity by affecting MAPK/ERK pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, potentially altering the signaling pathways associated with V1R10. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
Acts as a calmodulin antagonist, which could indirectly affect V1R10 signaling by modulating calcium signaling pathways. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A ROCK inhibitor, potentially affecting cytoskeletal arrangements, indirectly influencing V1R10 signaling. | ||||||